COMPASS Pathways
Altrincham
About COMPASS Pathways
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression. The company is involved in researching and developing psilocybin therapy, a psychedelic compound found in certain mushrooms, as a potential treatment for depression. Compass Pathways conducts clinical trials and research to assess the safety and efficacy of psilocybin-assisted therapy in patients who have not responded to conventional depression treatments. The company's goal is to bring evidence-based innovation to mental health care and address the significant unmet need for effective and accessible treatments for depression.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $771.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: nasdaq:CMPS
- Website: compasspathways.com
Industries & Categories
Biotechnology, Health Care, Life Science, Mental Health, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/compass-pathways-13034 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.